Remaining ‘vigilant’ is the key to disrupting the harmful influences of opioid prescribing to people at risk of addiction, US pharmacist-turned opioid misuse detective Dan Schneider told attendees at PSA21 Virtual today.

Medicine safety will be improved through empowering consumers and a combination of practice, policy and research initiatives.

A third of patients living with chronic pain have not had their medicine reviewed. An expert explains what pharmacists can do to change this.

On 11 July, 7.4 million Australians became eligible for a COVID-19 winter dose after the eligibility criteria widened.

Dispensing of psychotropic medicines to Australian children and adolescents aged 18 and younger doubled from 2013 to 2021, new research found.

For community pharmacist Ilwoo Park MPS, better remuneration begins with a better understanding of what pharmacists are worth.